A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advanced or recurrent gastric cancer resistant to S-1.

Trial Profile

A Randomised phase III clinical trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in patients with advanced or recurrent gastric cancer resistant to S-1.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 12 May 2016

At a glance

  • Drugs Cisplatin (Primary) ; Irinotecan (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Acronyms TRICS
  • Most Recent Events

    • 26 Jan 2013 Results presented at the 2013 Gastrointestinal Cancers Symposium.
    • 28 Sep 2012 Interim tolerability analysis presented at the 37th Congress of the European Society for Medical Oncology.
    • 28 Sep 2012 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top